AUG 19, 2020 8:54 AM PDT

Testing the Toxicity of CDK Inhibitors and Radiotherapy

WRITTEN BY: Jasper Cantrell

Drug targets often focus on one thing, inhibiting or activating some critical function in a cell. Cancer drugs are no different, usually targeting things like cell termination, immune cell activation, or the cell cycle.

Cyclin-dependent kinases (CDK) are key players in many cellular processes, most notably the cell cycle.  Inhibitors of certain cyclin-dependent kinases (CDK4 and 6, for example) are known to arrest the cell cycle, resulting in the cell’s termination in most cases. Some of these inhibitors have even been approved for the treatment of cancer, and are currently in use to treat breast cancer.

However, a team from Brescia University in Italy saw some missing information on these CDK based therapies. They found that there was no data on the toxicity of CDK inhibitors alongside radiotherapy. Radiation therapy is still a common anti-cancer treatment, so they sought to examine if the combination of CDK inhibitor chemotherapy alongside radiotherapy produced any abnormal toxicity.

They gathered breast cancer patient data from 18 patients at the university’s treatment center. Each patient in this group used either palbociclib, ribociclib, or abemciclib, with varying secondary factors. This retrospective intended to analyze the effectiveness of the treatment and the toxicity each patient faced during the treatment’s application.  

Overall, 17 of the 18 patients had achieved local control of the malignancy after radiotherapy and CDK inhibitor treatment. The toxicity was in line with what was expected from the CDK inhibitors, with one patient experiencing possible radio-sensitivity after palbociclib treatment. All patients experienced reduced pain, with 16 saying they had no pain after the full treatment.

This study showed that the radiotherapy alongside the three CDK inhibitors palbociclib, ribociclib, or abemciclib, did not have any abnormal toxicity. Two patients experienced high-grade adverse events, but they were resolved and kept on the therapy. Otherwise, the results from the patients in the study were quite positive.

The team notes that the data from this study is likely limited from its fairly small population size. 18 patients is relatively large compared to similar studies but is still small for most statistical analysis.

The study concludes, “Although the results of this study should be interpreted with caution, given the limited cohort, promising outcomes were reported both in terms of pain relief and local control of disease.

Sources: Nature Scientific Reports, ImedexCME

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
APR 07, 2021
Cancer
Does inhibiting NLRP3 inhibit melanoma tumor growth?
APR 07, 2021
Does inhibiting NLRP3 inhibit melanoma tumor growth?
Researchers at the University of Colorado Cancer Center have published exciting findings in the Proceedings of the Natio ...
MAY 17, 2021
Cancer
Cells at the center of a tumor are more aggressive and spread faster
MAY 17, 2021
Cells at the center of a tumor are more aggressive and spread faster
New research stemming from a collaboration between researchers from the Francis Crick Institute, Royal Marsden, UCL and ...
MAY 28, 2021
Genetics & Genomics
Some Biofilms Seem to Activate Cancer Genes
MAY 28, 2021
Some Biofilms Seem to Activate Cancer Genes
New research assessed bacterial and fungal biofilms, tenacious microbial communities that are tougher than small groups ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUN 11, 2021
Cancer
Man beats brain cancer with ketogenic diet
JUN 11, 2021
Man beats brain cancer with ketogenic diet
Glioblastoma brain cancer continues to be one of the most fatal cancers, responsible for approximately 15,000 death ever ...
JUN 22, 2021
Cancer
Evaluating adverse effects of induction therapy for neuroblastoma
JUN 22, 2021
Evaluating adverse effects of induction therapy for neuroblastoma
A study published in the Journal of Clinical Oncology reports an evaluation of the chemotherapy treatment given to child ...
Loading Comments...